跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
拉替拉韦钾咀嚼片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Raltegravir Potassium chewable tablets
Approved
化学药品
Raltegravir Potassium chewable tablets
Merck Sharp & Dohme BV
🇨🇳 National Medical Products Administration
Approval Date
Dec 15, 2020
Approval ID
887whfgSLCr
Company
Merck Sharp & Dohme BV
Type
化学药品
Approval Details
Approval Id
887whfgSLCr
Approval Number
国药准字HJ20200059
Generic Name
拉替拉韦钾咀嚼片
Generic Name En
Raltegravir Potassium chewable tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
按C20H20FN6O5计 25mg
Reg Date
2020-12-15
Expired Date
2025-12-14
Company Name
Merck Sharp & Dohme BV
Production Company Name
PATHEON PHARMACEUTICALS INC.
Company Detail Path
/organization/merck-sharp-and-dohme-bv
Production Company Detail Path
/organization/patheon-pharmaceuticals-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 15, 2020
Approval ID
887whfgSLCr
Type
化学药品
Back to NMPA Approvals